Tags

Type your tag names separated by a space and hit enter

[Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006; 12(1):45-50.ED

Abstract

The treatment of diabetes mellitus with a continuous subcutaneous insulin infusion (CSII) has become very popular and is well accepted by diabetic patients. Pump therapy mimics the physiological insulin secretion and has been shown to be a safe and effective method of insulin administration alternative to the method of multiple injections. Continuous insulin infusion provides greater flexibility in the timing of meals and snacks with higher treatment satisfaction. Programmed basal rates improve nocturnal glycemic control and help to minimize a pre-breakfast increase of blood glucose level (the dawn phenomenon). Moreover, CSII can reduce exercise-induced and nocturnal hypoglycemia. Insulin pump therapy is effective in lowering glycated hemoglobin levels without higher risk of severe hypoglycaemia and ketoacidosis. To achieve a proper metabolic control with this method of treatment, the patient and his family requires appropriate education including knowledge of diet management, insulin therapy and manual competence of pump device. Here we present general guidelines for patients education concerning insulin dosage, programming of basal insulin rates and meal boluses based on carbohydrates and protein-fat exchanges.

Authors+Show Affiliations

Szypowska A
II Katedra Pediatrii, Klinika Diabetologii, Patologii Noworodka i Wad Wrodzonych AM w Warszawie, Warszawa. szypowska@poczta.onet.pl
Pańkowska E
No affiliation info available
Lipka M
No affiliation info available

MeSH

ChildDiabetes Mellitus, Type 1Drug Administration ScheduleHumansHypoglycemiaHypoglycemic AgentsInfusion Pumps, ImplantableInsulinInsulin Infusion SystemsPractice Guidelines as Topic

Pub Type(s)

English Abstract
Journal Article

Language

pol

PubMed ID

16704861

Citation

Szypowska, Agnieszka, et al. "[Guidelines Concerning Insulin Dosage in Children and Adolescents With Type 1 Diabetes On Continuous Subcutaneous Insulin Infusion]." Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego : Organ Polskiego Towarzystwa Endokrynologow Dzieciecych, vol. 12, no. 1, 2006, pp. 45-50.
Szypowska A, Pańkowska E, Lipka M. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):45-50.
Szypowska, A., Pańkowska, E., & Lipka, M. (2006). [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion]. Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego : Organ Polskiego Towarzystwa Endokrynologow Dzieciecych, 12(1), 45-50.
Szypowska A, Pańkowska E, Lipka M. [Guidelines Concerning Insulin Dosage in Children and Adolescents With Type 1 Diabetes On Continuous Subcutaneous Insulin Infusion]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):45-50. PubMed PMID: 16704861.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion]. AU - Szypowska,Agnieszka, AU - Pańkowska,Ewa, AU - Lipka,Maria, PY - 2006/5/18/pubmed PY - 2006/8/3/medline PY - 2006/5/18/entrez SP - 45 EP - 50 JF - Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych JO - Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw VL - 12 IS - 1 N2 - The treatment of diabetes mellitus with a continuous subcutaneous insulin infusion (CSII) has become very popular and is well accepted by diabetic patients. Pump therapy mimics the physiological insulin secretion and has been shown to be a safe and effective method of insulin administration alternative to the method of multiple injections. Continuous insulin infusion provides greater flexibility in the timing of meals and snacks with higher treatment satisfaction. Programmed basal rates improve nocturnal glycemic control and help to minimize a pre-breakfast increase of blood glucose level (the dawn phenomenon). Moreover, CSII can reduce exercise-induced and nocturnal hypoglycemia. Insulin pump therapy is effective in lowering glycated hemoglobin levels without higher risk of severe hypoglycaemia and ketoacidosis. To achieve a proper metabolic control with this method of treatment, the patient and his family requires appropriate education including knowledge of diet management, insulin therapy and manual competence of pump device. Here we present general guidelines for patients education concerning insulin dosage, programming of basal insulin rates and meal boluses based on carbohydrates and protein-fat exchanges. SN - 1234-625X UR - https://www.unboundmedicine.com/medline/citation/16704861/[Guidelines_concerning_insulin_dosage_in_children_and_adolescents_with_type_1_diabetes_on_continuous_subcutaneous_insulin_infusion]_ DB - PRIME DP - Unbound Medicine ER -